Amid the Coronavirus, Cramer’s checking in with Clorox to learn more about the impact on the company’s bottom line and what’s on the horizon. Then, Boot Barn was down nearly 10% after reporting earnings, but could the declines present a buying opportunity? Cramer’s talking to the company’s CEO. Plus, the CEO of Teladoc joins Cramer to discuss the future of telemedicine and what the company is seeing this flu season.
